Table 2. Patient immunological... | Rockefeller University Press

Table 2.

Patient immunological phenotypes from the analysis of whole blood samples

Phenotype	P1	Normal range	P2	Normal range
Lymphocytes/μl	1,864		2,100
T cells
CD3⁺
%	77	56–84	66	56–75
/μl	1,435	1,000–2,200	1,386	1,400–3,700
CD4⁺
%	26	31–52	32	28–47
/mm³	485	530–1,300	672	700–2,200
CD8⁺
%	39	18–35	29	16–30
/mm³	727	330–920	609	490–1,300
CD45RA⁺/CD45⁺ (%)	72	58–70	79	73–86
CD31⁺CD45RA⁺/CD4⁺ (%)	53	43–55	41	57–65
CCR7⁺CD45RA⁺/CD8⁺ (%)	65	52–68	ND
CCR7⁺CD45RA⁻/CD8⁺ (%)	2	3–4	ND
CCR7⁻CD45RA⁻/CD8⁺ (%)	12	11–20	ND
CCR7⁻CD45RA+/CD8+ (%)	21	16–28	ND
B cells
CD19⁺
%	17	3.5–24	12	14–33
/μl	317	193–628	252	390–1,400
CD27⁺/CD19⁺ (%)	5	7–29	ND
CD27⁻IgD⁺/CD19⁺ (%)	90	61.6–87.4	ND
CD27⁺IgD⁺/CD19⁺ (%)	2	2.6–13.4	ND
CD27⁺IgD⁻/CD19⁺ (%)	3	4–21.2	ND
CD24⁺⁺CD38⁺⁺CD27⁻IgD⁺/CD19⁺ (%)	4	3.9–7.8	ND
CD24⁻CD38⁺⁺/CD19⁺ (%)	1	0.3–1.7	ND
CD21^lowCD38^low/CD19⁺ (%)	2	0.9–3.3	ND
NK cells
CD16⁺CD56⁺
%	6	3–22	16
/μl	112	70–480	336

Phenotype	P1	Normal range	P2	Normal range
Lymphocytes/μl	1,864		2,100
T cells
CD3⁺
%	77	56–84	66	56–75
/μl	1,435	1,000–2,200	1,386	1,400–3,700
CD4⁺
%	26	31–52	32	28–47
/mm³	485	530–1,300	672	700–2,200
CD8⁺
%	39	18–35	29	16–30
/mm³	727	330–920	609	490–1,300
CD45RA⁺/CD45⁺ (%)	72	58–70	79	73–86
CD31⁺CD45RA⁺/CD4⁺ (%)	53	43–55	41	57–65
CCR7⁺CD45RA⁺/CD8⁺ (%)	65	52–68	ND
CCR7⁺CD45RA⁻/CD8⁺ (%)	2	3–4	ND
CCR7⁻CD45RA⁻/CD8⁺ (%)	12	11–20	ND
CCR7⁻CD45RA+/CD8+ (%)	21	16–28	ND
B cells
CD19⁺
%	17	3.5–24	12	14–33
/μl	317	193–628	252	390–1,400
CD27⁺/CD19⁺ (%)	5	7–29	ND
CD27⁻IgD⁺/CD19⁺ (%)	90	61.6–87.4	ND
CD27⁺IgD⁺/CD19⁺ (%)	2	2.6–13.4	ND
CD27⁺IgD⁻/CD19⁺ (%)	3	4–21.2	ND
CD24⁺⁺CD38⁺⁺CD27⁻IgD⁺/CD19⁺ (%)	4	3.9–7.8	ND
CD24⁻CD38⁺⁺/CD19⁺ (%)	1	0.3–1.7	ND
CD21^lowCD38^low/CD19⁺ (%)	2	0.9–3.3	ND
NK cells
CD16⁺CD56⁺
%	6	3–22	16
/μl	112	70–480	336

ND, not done.